ATAT News
Archived Headlines
- US IPO Week Ahead: Biotech IPOs set to brave challenging market conditions 11/04/22
- Money makers: The 2022 IPO market puts profitability back on a pedestal 06/29/22
- Chinese issuers return to the US IPO market 06/24/22
- Chinese hotel chain Atour Lifestyle Holdings submits new blank filing ahead of $100 million US IPO 06/21/22
- Chinese hotel chain Atour Lifestyle Holdings sets terms for $286 million US IPO 06/24/21
See more
Renaissance Capital's November IPO Market Update
It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain ...read more
US IPO Weekly Recap: Chinese hotel chain leads a 3 IPO week
Three IPOs and one SPAC began trading this past week, though neither of the scheduled biotechs made it to market as Intensity Therapeutics (INTS) postponed and Acrivon Therapeutics (ACRV) delayed its pricing. One IPO and two...read more
Chinese hotel chain Atour Lifestyle Holdings prices US IPO at $11 low end
Atour Lifestyle Holdings, an upper midscale hotel chain in China, raised $52 million by offering 4.8 million ADSs at $11, the low end of the range of $11 to $13. The IPO float is just 3.6% of the basic shares outstanding. New investor Snow Lake had...read more
Chinese hotel chain Atour Lifestyle Holdings relaunches $57 million US IPO
Atour Lifestyle Holdings, an upper midscale hotel chain in China, filed new terms for its upcoming IPO on Monday. The Shanghai, China-based company now plans to raise $57 million by offering 4.8 million ADSs at a price range of $11 to $13. The IPO float is...read more